Psychological support for family caregivers of patients in intensive care for COVID-19
- Funded by Danish Independent Research Foundation
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$221,914.88Funder
Danish Independent Research FoundationPrincipal Investigator
Annika von HeymannResearch Location
DenmarkLead Research Institution
RigshospitaletResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Social impacts
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Relatives of critically ill patients with COVID-19 who are admitted to an intensive care unit are forced to deal with overwhelming uncertainty and confront the fundamental existential fear of death. Being a relative of a patient in an intensive care unit is already associated with post-traumatic stress and, in those where the patient dies during hospitalization, a prolonged grief reaction. The Corona pandemic in particular is cutting off relatives from using their social support network as usual. Despite this, there is currently no systematic psychosocial support for relatives in COVID-19 intermediate and intensive care units. In this project, we will develop and pilot test a tele-delivered psychological intervention for 50 relatives of patients with COVID-19 admitted to the intensive care unit at Rigshospitalet and Skejby Hospital. Weekly conversations with specially trained psychologists should support the relatives in dealing with the great emotional strain and reduce their risk of post-traumatic stress and prolonged grief. The intervention is composed of elements from existing psychological interventions tested by our research group and is developed based on feedback from relatives in the pilot project. If the pilot project proves promising, we will test the effect of the intervention in a randomized trial in the second wave of the pandemic, which is expected in the autumn.